709 filings
Page 3 of 36
8-K
jfc640oxpd5zshmra
27 Sep 22
New branding reflects Company’s vision to be the leader in the treatment of Stress Urinary Incontinence in Women
8:29am
CORRESP
h3s47vr6
26 Sep 22
Correspondence with SEC
12:00am
8-K
2zv0e0m5y zr
22 Sep 22
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
8:29am
8-K
2s2qjrz
15 Sep 22
Viveve to Participate in Alliance Global Partners Virtual MedTech Conference
8:29am
8-K
b2fstewhuy0r xcmg
1 Sep 22
Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
8:29am
8-K
soctbk6wy7tm s0mskec
11 Aug 22
Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
8-K
xjcqoxvos
12 Jul 22
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
8:29am
8-K
8b4o cniti4c8lmogw0z
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
abz5q9y
17 May 22
Viveve to Participate in H.C. Wainwright Global Investment Conference
4:29pm
8-K
gvv 0s339jlzaow1
12 May 22
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
xdf368f ks3u7c6xx255
9 May 22
Submission of Matters to a Vote of Security Holders
12:00am
8-K
laoks10gw52yrjl1b2
17 Mar 22
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
xcm6ot28g8t2x
21 Jan 22
Departure of Directors or Certain Officers
4:15pm
S-8
vy5uy9j
5 Jan 22
Registration of securities for employees
12:00am
8-K
hwhkg6um3 vhof
14 Dec 21
Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence
8:29am